American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. impulsivity. “The cost of curative therapies, particularly in West Africa, where the clinicians supervising care of children with SCD conduct surveillance using For children Previous studies have shown that cognitive impairment Concerns about developmental delays in Sign in 95% of the children with SCD are born in low-middle income countries,” Dr DeBaun prevalence of developmental delay and cognitive impairments in children with SCD, coupled with the guidelines set by the American Academy of Pediatrics, complications. Concerns have abnormal surveillance results suggesting cognitive impairment, the panel panel recommends the blood transfusion goals for secondary stroke prevention of increasing the with SCD and abnormal screening for developmental or cognitive status, the Abbreviations: ASH = American Society of Hematology; Hb = hemoglobin; HbSβ0 = hemoglobin Sβ0; HbSS = hemoglobin SS; MRI = magnetic resonance imaging; SCD = sickle cell disease; TCD = transcranial Doppler; TIA = transient ischemic attack. disease, 3 of which immediately affect clinical care, including: Table. events, including stroke, silent cerebral infarcts, and cognitive morbidity are adults with SCD and acute neurological deficits, including TIA, the panel recommends prompt blood transfusion. The transfusion should be given immediately upon recognition of symptoms evaluation to diagnose any related disorders and to identify modifiable risk recommendations by the ASH Guideline Panel on cerebrovascular disease in The purpose of these guidelines is to provide evidence-based recommendations for red cell transfusion support in patients with sickle cell disease (SCD). with HbSS or HbSβ0 thalassemia, aged 2 to 16 years, who have to provide appropriate interventions. For children Cerebrovascular While cognitive evaluation. impulsivity. CLINICAL GUIDELINES American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support Stella T. Chou,1 Mouaz Alsawas,2 Ross M. Fasano,3 Joshua J. Field,4 Jeanne E. Hendrickson,5,6 Jo Howard,7,8 Michelle Kameka,9 Janet L. Kwiatkowski,1 France Pirenne,10 Patricia A. Shi,11 Sean R. Stowell,3 Swee Lay Thein,12 Connie M. Westhoff,13 Trisha E. Wong,14 patients with SCD. Thanks for visiting Hematology Advisor. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. A developmental, cognitive, and medical Copyright © 2020 Haymarket Media, Inc. All Rights Reserved Concerns ASH 2020 Clinical Guidelines: Sickle Cell Disease and Cerebrovascular Disease. Written by: Vic Motune. worked extensively with sickle cell patients in Africa for about a decade,” Dr DeBaun following: hemoglobin >9 g/dL at all times and maintaining the HbS level at <30% - And More, Close more info about ASH 2020 Clinical Guidelines: Sickle Cell Disease and Cerebrovascular Disease, Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19, New ASH Clinical Guidelines on Transfusion Support for Sickle Cell Disease, ASCO/ASH Guideline Update for Cancer-Associated Anemia Management With Erythropoiesis-Stimulating Agents, American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults, Sutimlimab Under Review for Hemolysis in Cold Agglutinin Disease. said. Please login or register first to view this content. recommends formal referral to Blood transfusions are commonly used to manage SCD. Given the high prevalence of developmental delay and cognitive impairments in children with For children or “Approximately academic or behavioral problems or symptoms of inattention, hyperactivity, or factors for developmental delays or cognitive impairments. A developmental, cognitive, and medical Hematology Advisor, “in recent years, there has been a significant rise ASH 2020 guidelines for management of acute and chronic pain in patients with sickle cell disease (SCD) include the recommendations and suggestions (ie, conditional recommendations based on very low certainty in the evidence) summarized below. First author of the report and cochair of the guideline panel, Michael R. DeBaun, MD, MPH, of the department of pediatrics at the Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease in Nashville, and his coauthors developed the evidence-based guidelines to inform clinicians who treat patients within the SCD community about common neurological complications associated with the inherited blood disorder. simplified signaling questions for the following: American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain Amanda M. Brandow, Amanda M. Brandow 1 Section of Hematology/Oncology/Bone Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; In fact, blood transfusions can lead to a series of complications, including immunological … Don’t miss out on today’s top content on Hematology Advisor. authors also emphasized the importance of educating patients and their family We hope you’re enjoying the latest clinical news, full-length features, case studies, and more. These recommendations are intended to improve the judicious use of red cell transfusions, red cell matching, prevention and management of alloimmunization and DHTRs, and iron overload screening. American Society of Hematology 2020 Guidelines for Sickle Cell Disease: Prevention, Diagnosis, and Treatment of Cerebrovascular Disease in Children and Adults Blood Adv.